ANI Pharmaceuticals reported $29.13M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
AbbVie USD 5.81B 4.36B Dec/2025
ANI Pharmaceuticals USD 29.13M 6.3M Dec/2025
Aurora Cannabis CAD -44.75M 27.14M Sep/2025
Canopy Growth CAD -14.3M 17.19M Sep/2025
Eli Lilly USD 8.99B 1.57B Dec/2025
Heron Therapeutics USD 38K 3.83M Dec/2025
Hikma Pharmaceutical USD 348M 31M Dec/2025
Knight Therapeutics CAD 2.94M 2.4M Sep/2025
Nektar Therapeutics USD -34.34M 3.68M Sep/2024
Novartis USD 4.48B 343M Sep/2025
Omeros USD -48.15M 7.25M Sep/2023
Perrigo USD 84.4M 9M Dec/2025
Sun Pharmaceuticals INR 40.62B 6.95B Dec/2025
Teva Pharmaceutical Industries USD 577M 491M Dec/2025